PHARMA-BIO SERV, INC. (PBSV) Return on equity 2017–2025
PHARMA-BIO SERV, INC. (PBSV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-0.8%FY2025 · since FY2017: -6.8% → -0.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -0.8% | +4.8 pp |
| FY2024 | -5.7% | -13.8 pp |
| FY2023 | 8.1% | +2.0 pp |
| FY2022 | 6.1% | +17.1 pp |
| FY2021 | -11.0% | -20.1 pp |
| FY2020 | 9.0% | -1.1 pp |
| FY2019 | 10.1% | +3.8 pp |
| FY2018 | 6.3% | +13.1 pp |
| FY2017 | -6.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice